===TITLE===
LIC Stocks Plunge to 52-Week Lows on Rising Claims Fear
===META===
Life insurers LIC, HDFC Life, Bajaj Finserv, and ICICI Prudential hit 52-week lows on April 2, 2026, as Q4 results and a regulator's report on high claim rejections sparked a sector-wide sell-off.
===EXCERPT===
Shares of India's top life insurers crashed to their lowest levels in a year on Thursday. A regulator's report showing 34% of health claims were denied fueled the fire.
===TAGS===
LIC, HDFC Life, Bajaj Finserv, ICICI Prudential, IRDAI, 52-week low, stock market, Q4FY26 results, claim rejection ratio, life insurance
===BODY===
Shares of Life Insurance Corporation of India (LIC) led a sharp sector-wide decline on the BSE and NSE on Thursday, April 2, 2026, hitting their lowest intraday levels in 52 weeks. The fall was part of a broader market correction but was exacerbated by sector-specific fears. LIC's stock (BSE: 500500) fell 5.8% to ₹712.45 by 3:15 PM IST, down from its previous 52-week high of ₹985.20 on July 15, 2025.
And it wasn't just LIC. HDFC Life (BSE: 533215) dropped 6.2% to ₹592.80, Bajaj Finserv (BSE: 500032)—which owns Bajaj Allianz Life—slipped 5.4% to ₹7,850.15, and ICICI Prudential Life (BSE: 540525) tumbled 5.9% to ₹485.60. All four breached their respective 52-week low thresholds during the trading session. This synchronized drop wiped out over ₹12,400 crore in combined market capitalization within the first two hours of trade.
The immediate catalyst was the combination of weaker-than-expected quarterly earnings and a damning industry report. LIC reported its Q4FY26 results after market hours on March 30, 2026. Its net profit fell 18% year-on-year to ₹3,120 crore, missing analyst estimates. But the more alarming data point was the rise in its combined ratio for the quarter to 102.5%, indicating underwriting losses.
But the bigger shock came from the Insurance Regulatory and Development Authority of India's (IRDAI) annual report released on April 1, 2026. The report detailed that for the financial year 2025-26, the average claim rejection ratio across health insurance policies stood at 34%. This was up from 29% the previous year. The data sparked fears of regulatory tightening and reputational damage for insurers, particularly those with high exposure to health and linked products.
The numbers tell a clear story of sector distress. Trading volumes surged abnormally. LIC's volume hit 45.6 million shares by afternoon, 2.3 times its daily average. Panic selling was evident as the NIFTY 50 index itself fell only 1.1% in the same period, highlighting the isolated pressure on insurance stocks.
And this comes after a bruising quarter. In a linked development, a March 17, 2026, report from CareRatings had already flagged that general insurers, including health players, saw incurred claims ratio jump to 78% in Q3FY26. That pressure inevitably spills over to life insurers who also sell health and savings-linked policies. The market is connecting the dots.
One fund manager, speaking anonymously to Business Standard on April 2, stated, "The IRDAI data is a red flag. It implies higher future litigation costs and potential intervention." This sentiment was echoed in a note from Geojit Financial Services, which downgraded its rating on LIC to 'Reduce' on April 2, citing "margin pressure from rising claims and a low-interest rate environment."
The technical charts are grim. All four stocks had been in a downtrend since January 2026. Thursday's plunge broke through key support levels, triggering stop-loss orders from momentum traders. For LIC, the ₹725 level, which had acted as a minor support in early March, vanished instantly.
What about the business fundamentals? LIC's new business premium (Individual) for FY26 was down 4.7% year-on-year. Persistency ratios for the 13th month dropped to 67.4% from 69.1%. These are not just stock market figures; they represent core business health.
But is this overdone? Some analysts argue the sell-off is exaggerated. "The claim rejection ratio is an industry average. Companies with better underwriting tech, like HDFC Life, should outperform," said a research analyst from a local brokerage. However, the market isn't discriminating yet.
The timing is critical. With the fiscal year ending on March 31, 2026, the full-year impact of these high claims will be visible in annual reports due in May. Investors are exiting ahead of that risk clarity. The fear is that the 34% rejection figure might force IRDAI to mandate more transparent claims processes, increasing operational costs industry-wide.
In summary, it's a perfect storm: weak quarterly results, a regulator's adverse report, pre-annual-report caution, and negative technical momentum. The market is pricing in a tough FY27 for life and health insurers. For a typical retail investor holding these stocks via mutual funds or direct equity, the ₹712 price for LIC represents a 28% erosion of wealth from its 52-week high in just nine months. The sector's outlook now hinges on the operational metrics companies will disclose in their annual reports next month.
<a href="https://www.insuranceindiaa.in/category/finance">finance news</a>
<a href="https://www.insuranceindiaa.in/?p=13162">Insurers Lose ₹7,200 Crore in Q4FY26 Due to Auto Claims Surge</a>
